新光维医疗完成近4亿元A轮融资,全力打造全球领先的内窥镜及相关领域创新产品平台 Scivita Medical Technology Co., Ltd Apr 26, 2021 10:35 HKT/SGT Read More
新光維醫療完成近4億元A輪融資,全力打造全球領先的內窺鏡及相關領域創新產品平台 Scivita Medical Technology Co., Ltd Apr 26, 2021 10:34 HKT/SGT Read More
Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields Scivita Medical Technology Co., Ltd Apr 26, 2021 10:33 HKT/SGT Read More
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally Hua Medicine Apr 23, 2021 14:06 HKT/SGT Read More
Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan Eisai Apr 23, 2021 13:55 HKT/SGT Read More
아방스 클리니컬, 오라클 헬스 사이언스 커넥트에 초청되어 "분산형 실험 - 이전으로 돌아갈 수 없는 획기적 발전" 발표 Avance Clinical Apr 23, 2021 13:00 HKT/SGT Read More
Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies Eisai Apr 23, 2021 12:02 HKT/SGT Read More
Avance Clinical社がOracle Health Sciences Connectで「Decentralized Trials - No Going Back」と題した講演に招待されました Avance Clinical Apr 23, 2021 12:00 JST Read More
Notice Regarding Biogen's Disclosure About the Submission of Marketing Authorization Applications in Brazil, Canada, Australia, and Switzerland for Aducanumab for Alzheimer's Disease Eisai Apr 23, 2021 08:07 HKT/SGT Read More
Avance Clinical受邀發表“分散試驗–不再回頭” 適用於Oracle Health Sciences Connect Avance Clinical Apr 22, 2021 15:00 HKT/SGT Read More
Avance Clinical受邀发表“分散试验–不再回头” 适用于Oracle Health Sciences Connect Avance Clinical Apr 22, 2021 15:00 HKT/SGT Read More
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect Avance Clinical Apr 22, 2021 13:00 JST Read More
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect Avance Clinical Apr 22, 2021 12:00 HKT/SGT Read More
エーザイ、Lecanemab(BAN2401)の早期アルツハイマー病に対する18カ月の臨床第IIb相試験の結果が査読学術専門誌Alzheimer's Research and Therapy誌に掲載 Eisai Apr 20, 2021 11:00 JST Read More
Eisai: 18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer's Disease Eisai Apr 20, 2021 08:23 HKT/SGT Read More
Eisai to Present Latest Data on Neurology Products and Pipelines at the American Academy of Neurology Annual Meeting Eisai Apr 14, 2021 12:49 HKT/SGT Read More